Six-year follow-up data from a 16-patient trial show seven of eight responders to a personalized mRNA pancreatic cancer vaccine are still alive; experts call the findings highly promising but stress that larger trials must confirm the results
February 2020. Donna Gustafson arrived at an emergency room in Australia with suspected dehydration after a long flight. Doctors discovered she had pancreatic cancer. Nine days after returning to the United States, she underwent surgery to remove the... [10594 chars]